Sneddon syndrome: A Patient Guide

Sneddon syndrome is an exceptionally rare, chronic condition that affects the small and medium-sized blood vessels, primarily those in the skin and the brain. It is classically considered a non-inflammatory vasculopathy, meaning that the blood vessels typically become narrowed or blocked due to a progressive thickening of the vessel walls or the formation of tiny blood clots, rather than primary immune system inflammation ^[1][2]. However, the biology is not fully settled, and the syndrome can sometimes coexist with autoimmune conditions like lupus or antiphospholipid syndrome.

The most visible sign of the syndrome is livedo racemosa, a persistent, violet-colored skin pattern that often appears on the legs, arms, and torso. While this skin change is often the very first sign—sometimes appearing many years before any other health issues—the most significant concern for patients is the impact on the brain’s circulation. Because the vessels in the brain can become blocked in the same way as those in the skin, individuals with Sneddon syndrome are at a higher risk for ischemic strokes and transient ischemic attacks. Over time, these vascular changes can also affect cognitive functions, such as memory, attention, and the ability to plan and organize daily tasks ^[1][3]. The course and prognosis of Sneddon syndrome vary widely between patients; some remain stable for years, while others experience more progressive symptoms.

Living with Sneddon syndrome requires a shift in focus toward long-term vascular protection and secondary stroke prevention. Because the condition is chronic and can be progressive, the primary goal of care is to manage the risk of blood vessel blockage and to strictly control other cardiovascular risk factors that might further strain the blood vessels. This often involves a tailored approach to antithrombotic medication that is based on whether a patient has specific antibodies in their blood that increase clotting risk, among other individualized factors. Because the syndrome is classically non-inflammatory, standard treatments like steroids are typically not the cornerstone of therapy unless a coexisting autoimmune condition is present ^[4][5]. No single treatment guarantees prevention, and medication decisions require an experienced clinician.

A successful path forward involves building a dedicated team of specialists—including neurologists, dermatologists, and cardiologists—who can provide coordinated surveillance. Regular, individualized monitoring of brain, skin, and heart health is essential to catching subtle changes early and adjusting treatment as needed. While a diagnosis of Sneddon syndrome is life-altering, having a clear name for your symptoms and a structured plan for monitoring allows you to move from the uncertainty of a diagnostic search into a proactive phase of management. With the right care team and a focus on vascular health, the goal is to stabilize the condition and protect your quality of life for the long term ^[6][3].